LSP-249是血浆kallikrein的抑制剂，用于血管性水肿的研究，EC50值小于 100 nM。摘自专利WO2016011209A1。

LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.

1801253-04-2

C24H22ClN5O

431.92

DMSO:31.25 mg/mL (69.45 mM),ultrasonic and warming and heat to 60°C
Powder: -20°C for 3 years
In solvent: -80°C for 2 years